Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Standaert

Showing results (111-120 of 188) with videos related to

Pageof 19
Sort By:
Frontiers in Neurology|September 11, 2025
Inflammatory changes in early dementia with Lewy bodiesTalene A Yacoubian, Hongwei Qin, Amy Amara, et al.
Clinical Pharmacology and Therapeutics|August 31, 2021
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant EpilepsyBrittney H Davis, T Mark Beasley, Michelle Amaral, et al.
Human Molecular Genetics|November 19, 2004
Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1Birgit Zucker, Ruth Luthi-Carter, Jibrin A Kama, et al.
The Journal of Comparative Neurology|March 18, 2014
Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsAndrew B West, Rita M Cowell, João P L Daher, et al.
Science (New York, N.Y.)|May 4, 2002
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's diseaseAnthone W Dunah, Hyunkyung Jeong, April Griffin, et al.
Experimental Neurology|November 21, 2017
Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson diseaseAshley S Harms, Aaron D Thome, Zhaoqi Yan, et al.
Neurobiology of Disease|May 15, 2012
Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinAGiuseppe Sciamanna, Robert Hollis, Chelsea Ball, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 7, 2013
MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegenerationAshley S Harms, Shuwen Cao, Amber L Rowse, et al.
Neurology and Therapy|December 1, 2025
Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson's Disease: Post Hoc Analysis of a Randomized TrialAngelo Antonini, Bruno Bergmans, Drew S Kern, et al.
Neurobiology of Aging|October 26, 2005
Somatic mitochondrial DNA mutations in single neurons and gliaIppolita Cantuti-Castelvetri, Michael T Lin, Kangni Zheng, et al.
Pageof 19

Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
Frontiers in Neurology|September 11, 2025
Inflammatory changes in early dementia with Lewy bodiesTalene A Yacoubian, Hongwei Qin, Amy Amara, et al.
Clinical Pharmacology and Therapeutics|August 31, 2021
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant EpilepsyBrittney H Davis, T Mark Beasley, Michelle Amaral, et al.
Human Molecular Genetics|November 19, 2004
Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1Birgit Zucker, Ruth Luthi-Carter, Jibrin A Kama, et al.
The Journal of Comparative Neurology|March 18, 2014
Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsAndrew B West, Rita M Cowell, João P L Daher, et al.
Science (New York, N.Y.)|May 4, 2002
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's diseaseAnthone W Dunah, Hyunkyung Jeong, April Griffin, et al.
Experimental Neurology|November 21, 2017
Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson diseaseAshley S Harms, Aaron D Thome, Zhaoqi Yan, et al.
Neurobiology of Disease|May 15, 2012
Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinAGiuseppe Sciamanna, Robert Hollis, Chelsea Ball, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 7, 2013
MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegenerationAshley S Harms, Shuwen Cao, Amber L Rowse, et al.
Neurology and Therapy|December 1, 2025
Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson's Disease: Post Hoc Analysis of a Randomized TrialAngelo Antonini, Bruno Bergmans, Drew S Kern, et al.
Neurobiology of Aging|October 26, 2005
Somatic mitochondrial DNA mutations in single neurons and gliaIppolita Cantuti-Castelvetri, Michael T Lin, Kangni Zheng, et al.
Pageof 19